Sotera Health Company (SHC) vs Twist Bioscience Corporation (TWST)

Sotera Health Company and Twist Bioscience Corporation are both Diagnostics & Research companies. Twist Bioscience Corporation is the larger, with a market value of $9.5B against $5.2B — 1.8× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Sotera Health Company trades at 31.4×. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 8.15%. Sotera Health Company has the higher net margin (13.4% vs −31.7%) and the higher return on invested capital (9.82% vs −30.8%). Across the 18 metrics below, Sotera Health Company leads on 14 and Twist Bioscience Corporation on 4.

Valuation

Metric SHC TWST Diagnostics & Research median
P/E 31.39 n/m 35.56
P/S 4.20 19.18 4.37
P/B 7.68 18.58 3.06
Price to free cash flow 45.36 n/m 35.76
EV/EBITDA 13.18 n/m 24.35
EV/Sales 5.74 18.84 5.51
Earnings yield 3.19% (1.67%) (1.89%)
Free cash flow yield 2.20% (1.15%) (0.15%)

Profitability

Metric SHC TWST Diagnostics & Research median
Gross margin 54.97% 51.97% 50.89%
Operating margin 32.82% (33.58%) (8.57%)
Net margin 13.44% (31.66%) (6.37%)
Free cash flow margin 9.27% (22.15%) 0.00%
Return on equity 27.78% (29.59%) (2.92%)
Return on assets 5.01% (20.78%) (6.71%)
Return on invested capital 9.82% (30.83%) 0.00%

Growth

Metric SHC TWST Diagnostics & Research median
Revenue growth (TTM) 8.15% 19.19% 7.69%
EPS growth (last fiscal year) 68.75% 63.89% 25.92%
Revenue growth, 5-year CAGR 7.30% 33.11% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SHC TWST Diagnostics & Research median
Debt to equity 3.35 0.03 0.11
Current ratio 2.80 2.67 2.02
Net debt to EBITDA 3.74 1.95 0.70

Dividend

Metric SHC TWST Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric SHC TWST Diagnostics & Research median
Market cap 5.16b 9.51b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack